Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2008-05-27
2008-05-27
Desai, Rita (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C564S220000, C564S185000, C514S237500, C514S471000, C514S378000, C514S448000, C514S354000, C514S406000, C514S620000, C514S249000, C514S361000, C514S357000, C544S168000, C544S355000, C546S323000, C546S337000, C548S248000, C548S374100, C548S127000, C549S487000, C549S072000
Reexamination Certificate
active
10597127
ABSTRACT:
A compound of the formula (I) wherein the variables X1, X2, B, D, R1to R7including R3′, p, y, q, and z, are as defined or a pharmaceutically acceptable salt, solvate, enantiomer, racemate, diastereomer or mixtures thereof, useful for the treatment, prevention or amelioration of obesity and Related Diseases is disclosed
REFERENCES:
patent: 2456258 (1948-12-01), Dohrn et al.
patent: 3976784 (1976-08-01), Coles et al.
patent: 5077304 (1991-12-01), Pascual
patent: 5084449 (1992-01-01), Seydel et al.
patent: 5883096 (1999-03-01), Lowe et al.
patent: 1 113 000 (2001-07-01), None
patent: 1 193 255 (2002-04-01), None
patent: 2 291 743 (1976-06-01), None
patent: 2001064176 (2001-03-01), None
patent: 2001089412 (2001-04-01), None
patent: WO 99/33806 (1999-07-01), None
patent: WO 00/59878 (2000-10-01), None
patent: WO 02/12224 (2002-02-01), None
patent: WO 02/078693 (2002-10-01), None
patent: WO 03/002519 (2003-01-01), None
patent: WO 2004/026305 (2004-04-01), None
patent: WO 2004/080968 (2004-09-01), None
patent: WO 2004/080996 (2004-09-01), None
patent: WO 2004/093800 (2004-11-01), None
patent: WO 2005/061442 (2005-07-01), None
patent: WO 2005/066164 (2005-07-01), None
Database Caplus “online,” Chemical Abstracts Service, Takahashi, et al, “Pyridine derivatives containing sulfur IV. Snythesis of nitro and aminopyridines,” XP002338663.
Database Caplus “online,” Chemical Abstracts Service, Acharya, et al., “Synthesis of substituted phenyl 2-pyridyl ethers,” XP002338664.
Wenner, et al., “4-Aminomethyl-4'-aminodiphenyl sulfone and related compounds,” Journal of Organic Chemistry, vol. 22, pp. 5508-5513 (1957).
Surrey, et al, “Sulfides and sulfones of pyridine and quinoline,” Journal of the American Chemical Society, vol. 63, p. 173 (1940).
Mitch Charles Howard
Quimby Steven James
Siegel Miles Goodman
Demeter John C.
Desai Rita
Eli Lilly and Company
Ginah Francis O.
O'Dell David K
LandOfFree
Diphenylether amide derivatives as opioid receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diphenylether amide derivatives as opioid receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diphenylether amide derivatives as opioid receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3911761